Skip to content
MENU
SELECTED
PUBLICATIONS
2021
Intravenous Injection of Muse Cells as a Potential Therapeutic Approach for Epidermolysis Bullosa
LEARN MORE
2020
Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis
LEARN MORE
2020
Muse cell spheroids have therapeutic effect on corneal scarring wound in mice and tree shrews
LEARN MORE
2020
Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice
LEARN MORE
2020
A Novel Type of Stem Cells Double-Positive for SSEA-3 and CD45 in Human Peripheral Blood
LEARN MORE
2019
Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting
LEARN MORE
Page
1
Page
2
Page
3
Page
4
Page
5
Clinical Trials & Clinical Data
2024
Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis
LEARN MORE
2024
Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)
LEARN MORE
2024
Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial
LEARN MORE
2024
Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatmen
LEARN MORE
2023
Safety and Clinical Effects of a Muse Cell-Based Product in Patients With Amyotrophic Lateral Sclerosis: Results of a Phase 2 Clinical Trial
LEARN MORE
2023
Randomized placebo-controlled trial of CL2020, an allogenic muse cell-based product, in subacute ischemic stroke
LEARN MORE
Page
1
Page
2
Page
3
NEWS
2024
Muse Cells: A New Stem Cell Treatment
LEARN MORE
Home
Our Science
About
Publications
Contact
Home
Our Science
About
Publications
Contact
